List of companies in Ambria Capital's investment portfolio

A company offering a compliance platform for marketing cannabis products.

Wesana Health Holdings Inc is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma.

Developer of psilocybin-based medicines intended to treat disorders of the central nervous system. The company provides psychopharmacology, biotechnology, life sciences, neuropsychiatry, drug development, clinical trials, research, clinical drug development, psychopharmacology and psychedelic medicines.

Operator of cannabis company intended to bring high-quality branded cannabis products to market. The company offers a variety of selection of products with full-spectrum cannabis flowers, concentrates and consumables available at retailers nationwide, enabling consumers with premium products at affordable prices.

Operator of a mental health platform designed to offer psychedelic treatment for mental wellness. The company's platform helps people with accurate and honest information about psychedelic-assisted therapy including integrative mental health, and ketamine clinics across the world.

Developer of a psychedelic practice management platform designed to track, manage, measure, and illustrate health outcomes. The company's platform offers personalized protocols and psychedelic-specific assessments to track dosages, wellness outcomes, and psychological measures.

Developer of healthcare technology intended to provide drug discovery service. The company specializes in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases, enabling patients to get advanced drugs to treat them fast.

Provider of education, clinical care and clinical tools intended for the psychedelic medical sector. The company offers the therapeutic use of psychedelic-assisted therapies, integrative mental healthcare delivery and tools for novel modalities of care, thereby ensuring delivery of safe and effective therapy.

Developer of novel therapies designed to treat common nervous system disorders. The company uses a novel, allosteric modulation approach to discover novel therapies that would bind at the 5HT receptors in the brain.p

Developer of nanotechnology intended for theranostic applications. The company's nanotechnology is used for theranostic applications to effectively improve psychedelic drug efficacy through patented nanotechnology which, in combination with targeted delivery and controlled dosing technology methods.

Wonder sciences is a life sciences ecosystem pioneering the intersection of psychedelic medicine and science.